WASHINGTON — Raj Panjabi has made a career out of taking on some of public health’s toughest challenges, from malaria to Ebola to Covid-19 to mpox.
Panjabi’s next act will be leading a team at Flagship Pioneering. That team, which is focused on preventative medicine, has been around for three years.
The group could grow under four main categories, Panjabi said: preparing for infectious disease threats, delaying the onset of disease, biosecurity, and pursuing bolder early treatments for diseases with public health consequences like obesity, cancer, and neurodegenerative illnesses.
